Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 59, Number 9, November 12, 2002
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Waele, C.
Right arrow Articles by Tran Ba Huy, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Waele, C.
Right arrow Articles by Tran Ba Huy, P.
Related Collections
Right arrow All Clinical trials
Right arrow All Neurotology
Right arrow Audition
Right arrow Vertigo
Right arrow Clinical trials Observational study (Cohort, Case control)

Neurology 2002;59:1442-1444
© 2002 American Academy of Neurology
Brief Communications

Intratympanic gentamicin injections for Meniere disease Vestibular hair cell impairment and regeneration

C. de Waele, MD, PhD, R. Meguenni, MD, G. Freyss, MD, F. Zamith, N. Bellalimat, P.P. Vidal, MD, PhD and P. Tran Ba Huy, MD

From Service ORL, Hôpital Lariboisière (Drs. Freyss and Tran Ba Huy and F. Zamith and N. Bellalimat), and Laboratoire de Neurobiologie des Réseaux Sensori-moteurs (Drs. de Waele, Meguenni, and Vidal), Paris, France.

Address correspondence and reprint requests to Dr. Catherine de Waele, Laboratoire de Neurobiologie des Réseaux Sensori-moteurs, Faculté de Médecine, 45 rue des Saints Pères, 75270 Paris Cedex 06, France; e-mail: cdw{at}ccr.Jussieu.fr

The authors treated 22 patients with intratympanic gentamicin. Vestibular function was measured using caloric and head impulse tests and vestibular evoked myogenic potentials induced by high amplitude sounds and short duration galvanic currents. Roughly one-third of the patients, after initially losing their caloric responses and displaying refixation saccades to head impulse tests, recovered within 2 years of the lesion. Vertigo did not recur in patients in whom the galvanic response was abolished.




This article has been cited by other articles:


Home page
 NeurologyHome page
S. T. Aw, M. J. Todd, G. E. Aw, K. P. Weber, and G. M. Halmagyi
Gentamicin vestibulotoxicity impairs human electrically evoked vestibulo-ocular reflex
Neurology, November 25, 2008; 71(22): 1776 - 1782.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. S. Welgampola and J. G. Colebatch
Characteristics and clinical applications of vestibular-evoked myogenic potentials
Neurology, May 24, 2005; 64(10): 1682 - 1688.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
T. Murofushi, H. Monobe, A. Ochiai, and H. Ozeki
The site of lesion in "vestibular neuritis": Study by galvanic VEMP
Neurology, August 12, 2003; 61(3): 417 - 418.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.